SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA.

Hoffman, Seth A; Costales, Cristina; Sahoo, Malaya K; Palanisamy, Srikanth; Yamamoto, Fumiko; Huang, ChunHong; Verghese, Michelle; Solis, Daniel A; Sibai, Mamdouh; Subramanian, Aruna; Tompkins, Lucy S; Grant, Philip; Shafer, Robert W; Pinsky, Benjamin A

Hoffman, Seth A; Costales, Cristina; Sahoo, Malaya K; Palanisamy, Srikanth; Yamamoto, Fumiko; Huang, ChunHong; Verghese, Michelle; Solis, Daniel A; Sibai, Mamdouh; Subramanian, Aruna; Tompkins, Lucy S; Grant, Philip; Shafer, Robert W; Pinsky, Benjamin A.

Emerg Infect Dis ; 27(10): 2720-2723, 2021.

Article en En | MEDLINE | ID: mdl-34296992

Asunto(s)

Síndrome de Inmunodeficiencia Adquirida; COVID-19; Humanos; Mutación; Unión Proteica; SARS-CoV-2; Glicoproteína de la Espiga del Coronavirus/genética

Palabras clave

2019 novel coronavirus disease; COVID-19; California; HIV/AIDS; SARS-CoV-2; United States; antimicrobial resistance; coronavirus disease; coronaviruses; immunocompromised; respiratory infections; severe acute respiratory syndrome coronavirus 2; viral evolution; viruses; zoonoses

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Inmunodeficiencia Adquirida / COVID-19 Límite: Humans Idioma: En Revista: Emerg Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google